Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Broad Institute
Cambridge, Estados UnidosPublicacions en col·laboració amb investigadors/es de Broad Institute (12)
2024
-
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma
Blood cancer discovery, Vol. 5, Núm. 3, pp. 146-152
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory
Cancer Cell, Vol. 41, Núm. 11, pp. 1911-1926.e8
2022
-
WAT3R: recovery of T-cell receptor variable regions from 3′ single-cell RNA-sequencing
Bioinformatics, Vol. 38, Núm. 14, pp. 3645-3647
2017
-
The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma
Cell Reports, Vol. 19, Núm. 1, pp. 218-224
2016
-
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Science Translational Medicine, Vol. 8, Núm. 341
-
Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome
Nature Communications, Vol. 7
2015
-
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types
Journal of the National Cancer Institute, Vol. 107, Núm. 12
-
Characterization of large structural genetic mosaicism in human autosomes
American Journal of Human Genetics, Vol. 96, Núm. 3, pp. 487-497
2014
-
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33
Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633
2012
-
A DNA methylation fingerprint of 1628 human samples
Genome Research, Vol. 22, Núm. 2, pp. 407-419
2011
-
Long-range epigenetic silencing associates with deregulation of Ikaros targets in colorectal cancer cells
Molecular Cancer Research, Vol. 9, Núm. 8, pp. 1139-1151